Burnett J - Search Results

1

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.

Sun L, Burnett J, Gasparyan M, Xu F, Jiang H, Lin CC, Myers I, Korkaya H, Liu Y, Connarn J, He H, Zhang N, Wicha MS, Sun D. Sun L, et al. Among authors: burnett j. Oncotarget. 2016 Aug 9;7(32):51408-51422. doi: 10.18632/oncotarget.9839. Oncotarget. 2016. PMID: 27285982 Free PMC article.

2

Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.

Sun L, Guo C, Burnett J, Yang Z, Ran Y, Sun D. Sun L, et al. Among authors: burnett j. Oncotarget. 2016 Nov 29;7(48):78688-78697. doi: 10.18632/oncotarget.12798. Oncotarget. 2016. PMID: 27780921 Free PMC article.

3

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.

Sun L, Yuan H, Burnett J, Gasparyan M, Zhang Y, Zhang F, Yang Z, Ran Y, Sun D. Sun L, et al. Among authors: burnett j. Int J Med Sci. 2019 Jan 1;16(1):68-74. doi: 10.7150/ijms.27595. eCollection 2019. Int J Med Sci. 2019. PMID: 30662330 Free PMC article.

4

Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment options.

Burnett JP, Korkaya H, Ouzounova MD, Jiang H, Conley SJ, Newman BW, Sun L, Connarn JN, Chen CS, Zhang N, Wicha MS, Sun D. Burnett JP, et al. Sci Rep. 2015 Nov 2;5:15821. doi: 10.1038/srep15821. Sci Rep. 2015. PMID: 26522776 Free PMC article.

5

Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.

Paholak HJ, Stevers NO, Chen H, Burnett JP, He M, Korkaya H, McDermott SP, Deol Y, Clouthier SG, Luther T, Li Q, Wicha MS, Sun D. Paholak HJ, et al. Among authors: burnett jp. Biomaterials. 2016 Oct;104:145-57. doi: 10.1016/j.biomaterials.2016.06.045. Epub 2016 Jun 23. Biomaterials. 2016. PMID: 27450902 Free PMC article.

6

Targeting cancer stem cells with natural products.

Burnett J, Newman B, Sun D. Burnett J, et al. Curr Drug Targets. 2012 Jul;13(8):1054-64. doi: 10.2174/138945012802009062. Curr Drug Targets. 2012. PMID: 22594473 Review.

7

CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer.

Sun L, Wang Y, Yuan H, Burnett J, Pan J, Yang Z, Ran Y, Myers I, Sun D. Sun L, et al. Among authors: burnett j. J Cancer. 2016 Jun 18;7(10):1197-204. doi: 10.7150/jca.15209. eCollection 2016. J Cancer. 2016. PMID: 27390594 Free PMC article.

8

Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer.

Sun L, Guo C, Yuan H, Burnett J, Pan J, Yang Z, Ran Y, Myers I, Sun D. Sun L, et al. Among authors: burnett j. Am J Transl Res. 2016 Nov 15;8(11):5071-5075. eCollection 2016. Am J Transl Res. 2016. PMID: 27904708 Free PMC article.

9

Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.

Sun L, Guo C, Cao J, Burnett J, Yang Z, Ran Y, Sun D. Sun L, et al. Among authors: burnett j. Int J Med Sci. 2017 Jun 22;14(7):655-661. doi: 10.7150/ijms.18736. eCollection 2017. Int J Med Sci. 2017. PMID: 28824297 Free PMC article.

10

Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.

Wang Y, Xie Y, Niu Y, Song P, Liu Y, Burnett J, Yang Z, Sun D, Ran Y, Li Y, Sun L. Wang Y, et al. Among authors: burnett j. Int J Med Sci. 2021 Feb 18;18(8):1753-1759. doi: 10.7150/ijms.54954. eCollection 2021. Int J Med Sci. 2021. PMID: 33746592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,631 results

Search Page